Navigating the Intersection of FDA and CMS Policy: Implications of Post-Election Regulatory Shifts
December 12, 2024
WEBINAR
December 12, 2024 12:00 PM — 1:00 PM
This is the first part in a two-part webinar series focused on the recent election and areas of healthcare that we will be watching closely as the new administration begins to take shape.
Part One:
Watch the recording of a legal analysis of how recent election outcomes may influence regulatory frameworks under the CMS, HRSA, and the FDA. This webinar provided high-level insights into potential changes to healthcare policies, drug and device approvals, reimbursement strategies, and compliance priorities. Viewers will gain a better understanding of how these developments could impact stakeholders in the life sciences and healthcare industries.
Key Topics:
Election Outcomes and Healthcare Policy Priorities
Please note that CLE credit is only valid for live attendance. At this time, we are not able to provide credit for recorded views. Please contact us for details.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
